Webinar Related News
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
Webinar | 31 October 2024
The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment
ONCOLife | 9 October 2024
The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC
ONCOLife | 7 October 2024
The Future of Oncolytic Viruses and Their Role in Cancer Treatment
ONCOLife | 3 October 2024
The Role of AI in the Future of Drug Discovery: Redefining Accuracy...
Digital Health | 2 October 2024
The OVATION 2 Study and the Novel Immunotherapy IMNN-001 for Ovarian Cancer
ONCOLife | 12 September 2024
Exploring The Potential of Cytokine Therapies to Transform Cancer Treatment
ONCOLife | 29 August 2024
Lung Cancer Treatment for Never Smokers: The HARMONIC Phase 2 Trial and LP-300
ONCOLife | 19 August 2024
The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan
Pharma | 9 August 2024
Subscribe for the latest news and events
Most Popular
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
Novartis and Legend Biotech Strike $1 Billion Deal on CAR-T Therapy for Lung Cancer
A New Horizon in Rare Disease Treatment: FDA Approves Wainua for ATTR-PN
The Impact of CAR-T Cell Therapies on the Future of Pediatric Cancer Care
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
FDA Finds No Evidence Linking GLP-1 Weight-Loss Drugs to Suicidal Thoughts
Revolutionary Molecular Jackhammers: A 99% Success Rate in Eradicating Cancer Cells
A New Phase in Bladder Cancer Treatment: Nivolumab Combination Wins FDA Approval
FDA Approves Keytruda in Combination with Chemo-radiotherapy for Cervical Cancer
ESMO 2023: BioNTech Unveils Groundbreaking Results for Solid Tumor Treatment